Notice of Results

RNS Number : 4320P
Circassia Pharmaceuticals Plc
08 February 2019
 

8 February 2019

 

 

Circassia Pharmaceuticals plc

 

Notice of Preliminary Results

 

 

Circassia Pharmaceuticals plc (LSE: CIR) will announce its preliminary results for the year ended 31 December 2018 on Wednesday 1 May 2019. 

 

A presentation for analysts will take place at the offices of FTI Consulting, 200 Aldersgate, Aldersgate Street, London, EC1A 4HD at 9.30am.  A webcast of the presentation will be available on the Company's website.

 

 

Contacts

Circassia

Steve Harris, Chief Executive Officer                                                      Tel: +44 (0) 1865 405 560

Julien Cotta, Chief Financial Officer

Rob Budge, Corporate Communications

 

Peel Hunt (Nominated Adviser and Joint Broker)

James Steel / Dr Christopher Golden                                                      Tel: +44 (0) 20 7418 8900

 

Numis Securities (Joint Broker)

James Black / Freddie Barnfield                                                              Tel: +44 (0) 20 7260 1000

 

FTI Consulting

Simon Conway / Ciara Martin                                                                  Tel: +44 (0) 20 3727 1000


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NORFMGGZNNDGLZM

Companies

Niox Group (NIOX)
UK 100

Latest directors dealings